WMP is a private equity investment firm established under the laws of Delaware in May 2015. On behalf of its advisory clients, WMP invests primarily in the natural consumer health sector of the health and wellness industry. WMP focuses investments on lower middle market companies with branded products in the natural consumer health sector of the health and wellness industry. As a private equity fund manager, WMP seeks to create value in portfolio companies owned by the Funds (defined below) by working with management to implement operational enhancements and efficiencies. WMP’s investment management services are provided directly to the Funds and not individually to the limited partners of the Funds (collectively, the “Investors”). Alejandro Weinstein and Jose Minski are the principal owners of WMP, through entities controlled and beneficially owned by each, and together with Ernesto Carrizosa are the partners of WMP (the “Managing Principals”). The general partner of WMP is WM Partners GP II, LLC, a Delaware limited liability company formed in June 2018. WMP’s advisory clients currently consist solely of pooled investment vehicles (private funds) that are offered exclusively to qualified investors on a private placement basis (the “Funds” and individually, a “Fund”). The Funds accommodate a variety of different Investors and make a variety of different investments through the use of parallel vehicles, feeder funds, master funds, co-investment vehicles, employee vehicles, alternative investment vehicles and other entities domiciled in the United States and overseas jurisdictions, as applicable. Unless otherwise indicated, references in this Brochure to a “Fund” includes all such related vehicles comprising the Fund. The Funds are not required to be registered under the Investment Company Act of 1940 (as amended) or the Securities Act of 1933 (as amended), and Investors in the Funds do not receive the same level of protection and reporting as investment vehicles or issuers registered under such legislation. As of December 31, 2023, WMP has sponsored three Funds, two of which are currently active. The Funds’ principal investment strategy is to make growth equity and buyout investments in lower-middle market companies with branded products engaged in the natural consumer health sector of the health and wellness industry. WMP seeks to achieve the Funds’ investment objective by targeting acquisitions of and investments in companies focused on, among others, functional foods, natural personal care products, natural over-the-counter (“OTC”) products/natural remedies, and traditional OTC medicines. WMP may

also invest on behalf of the Funds in companies focused on different, or more specific, categories in the natural consumer health sector of the health and wellness industry, such as pet care and vitamins, minerals and supplements. The Funds’ objective is to seek investments that preserve capital and generate attractive risk-adjusted returns. This investment approach has been developed by WMP’s senior management in other business endeavors over the past 37 years and has formed the foundation for each Fund. The Funds generally seek to participate in majority-controlled buyout transactions as part of a roll-up strategy involving distinct platform companies in some or all of the health and wellness categories discussed above. The Funds may also allocate capital to growth equity minority investments with significant minority rights. To the extent that the opportunity arises, a Fund may consider engaging in a transformational deal involving one or more of its platform investments. The Funds intend to invest predominantly in companies located in the United States, but may invest in companies located outside the United States, such as Canada, Europe, Latin America, Asia and Israel, to the extent appropriate. Management of Funds WMP’s regulatory assets under management, all of which are attributable to private funds managed on a discretionary basis, as of December 31, 2023, were $1,085,288,738. WMP does not manage any assets on a non-discretionary basis. WMP manages the assets of the Funds on a discretionary basis in accordance with the terms of the Funds’ governing documents. Pursuant to separate investment management agreements with each Fund, WMP exercises discretionary authority with respect to the origination, investigation, structuring, finance, acquisition, monitoring, and disposition of investments for the Funds. Investments for the Funds are managed in accordance with each Fund’s particular investment objectives, strategies, and guidelines. Investments in the Funds are not tailored to the individual needs of any particular Investor. More complete information about the Funds, and the particular investment objectives, strategies, guidelines, and risks associated with an investment in each Fund, is included in its respective confidential private placement memorandum (the “PPM”) and other governing documents including its respective partnership agreements (the “Partnership Agreement(s)”), which are available to qualified investors only from WMP (or another party authorized by WMP to provide them). An investment in a Fund does not create an advisory relationship between the Investor and WMP.